Similar articles

• Blue Ribbon Committee on Bloodborne Parasitic Diseases.

  Health Canada, Bureau of Infectious Diseases, Centre for Infrectious Disease Prevention and Control. Health Canada, Bureau of Infectious Diseases, Centre for Infrectious Disease Prevention and Control. Can Commun Dis Rep. 2002 Sep;28 Suppl 3:1-23 (Eng), 1-27 (Fre). Can Commun Dis Rep. 2002. PMID: 12845878 Review. English, French.
• Chagas disease: clinical overview and implications for nursing.

  Lennox HA, Karcz DA, Tales H, El Masri M. Lennox HA, et al. Medsurg Nurs. 2007 Aug;16(4):229-35; quiz 236. Medsurg Nurs. 2007. PMID: 17907695 Review.
• New insights on the spread of Triatoma infestans from Bolivia--implications for Chagas disease emergence in the southern cone.

  Cortez MR, Monteiro FA, Noireau F. Cortez MR, et al. Infect Genet Evol. 2010 Mar;10(2):350-3. doi: 10.1016/j.meegid.2009.12.006. Epub 2010 Jan 7. Infect Genet Evol. 2010. PMID: 20060504
• [PAHO/WHO --Task force on the initiative of the South Cone for the elimination of vector transmission and interruption of transfusion transmission of Trypanosoma cruzi. Epidemiologic surveillance of Triatoma infestans].

  Dias JC. Dias JC. Rev Soc Bras Med Trop. 1993;26 Suppl 3:39-44. Rev Soc Bras Med Trop. 1993. PMID: 7855358 Portuguese. No abstract available.
• Potential novel risk factors for autochthonous and sylvatic transmission of human Chagas disease in the United States.

  Garcia MN, Hotez PJ, Murray KO. Garcia MN, et al. Parasit Vectors. 2014 Jul 4;7:311. doi: 10.1186/1756-3305-7-311. Parasit Vectors. 2014. PMID: 24996479 Free PMC article.